NCT07701772

Brief Summary

This single-center prospective randomized parallel-group trial compares laser ablation and crystallized phenol application in adults with primary uncomplicated sacrococcygeal pilonidal sinus disease. The primary objective is to compare postoperative day 1 pain intensity between the two treatment methods. Secondary objectives include complete epithelialization by day 30, time to complete epithelialization, postoperative day 7 pain, duration of analgesic use, time to return to daily activities and work, early local complications, and 6-month recurrence.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Jul 2026Mar 2027

First Submitted

Initial submission to the registry

July 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

July 15, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 8, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

Pilonidal sinus diseaseLaser ablationCrystallized phenolRandomized trialPostoperative painRecurrenceComplete epithelialization

Outcome Measures

Primary Outcomes (1)

  • Postoperative day 1 pain score

    Pain intensity on postoperative day 1 assessed using a 0 to 10 Visual Analog Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.

    Postoperative day 1

Secondary Outcomes (8)

  • Complete epithelialization at day 30

    Postoperative day 30

  • Time to complete epithelialization

    Up to 30 days

  • Postoperative day 7 pain score

    Postoperative day 7

  • Duration of analgesic use

    Up to 30 days

  • Time to return to daily activities

    Up to 30 days

  • +3 more secondary outcomes

Study Arms (2)

Laser ablation

EXPERIMENTAL

Participants undergo shared sinus preparation followed by laser ablation using a Leonardo Mini 1470 nm diode laser.

Procedure: Laser Ablation

Crystallized phenol

ACTIVE COMPARATOR

Participants undergo shared sinus preparation followed by crystallized phenol application to the sinus cavity.

Procedure: Crystallized phenol application

Interventions

After a small incision, hair and debris removal, and curettage, laser ablation is performed using a Leonardo Mini 1470 nm diode laser.

Laser ablation

After a small incision, hair and debris removal, and curettage, crystallized phenol is applied to the sinus cavity.

Crystallized phenol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Diagnosis of primary chronic sacrococcygeal pilonidal sinus disease
  • Uncomplicated disease
  • Suitability for minimally invasive treatment
  • Provision of written informed consent

You may not qualify if:

  • Acute pilonidal abscess
  • History of pilonidal abscess drainage
  • Previous surgical or interventional treatment for pilonidal sinus disease
  • Recurrent pilonidal disease
  • Complex pilonidal disease or marked lateral extension
  • Immunosuppression, chronic steroid use, or systemic conditions that may significantly impair wound healing
  • Inability to attend regular follow-up
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, PostoperativeRecurrence

Interventions

Laser Therapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized in a 1:1 ratio to either laser ablation or crystallized phenol treatment in a parallel-group design.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 14, 2026

Study Start

July 15, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

July 14, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because this is a single-center clinical study involving sensitive patient-level data, and there is no pre-specified institutional mechanism for external data sharing. Only aggregated, de-identified study results will be reported.